Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
7,254,615
-
Total 13F shares
-
4,474,800
-
Share change
-
-81,484
-
Total reported value
-
$20,493,118
-
Price per share
-
$4.58
-
Number of holders
-
38
-
Value change
-
-$400,160
-
Number of buys
-
11
-
Number of sells
-
12
Institutional Holders of Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR) as of Q2 2025
As of 30 Jun 2025 Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR) had 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,474,800 shares of stock of the company.
Largest 10 holders included TANG CAPITAL MANAGEMENT LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, BML Capital Management, LLC, Avidity Partners Management LP, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, Stonepine Capital Management, LLC, ADAR1 Capital Management, LLC, ACADIAN ASSET MANAGEMENT LLC, and Peapod Lane Capital LLC.
This table shows 38 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.